Immunoglobulin G specific for Stemphylium solani allergens (IgG-S. solani)

Immunoglobulin G (IgG) antibodies specific for Stemphylium solani allergens are glycoproteins produced by the human immune system following exposure to the fungal pathogen Stemphylium solani (Source: WHO/IUIS Allergen Nomenclature). While IgE antibodies are the primary mediators of Type I hypersensitivity reactions such as asthma and allergic rhinitis, specific IgG antibodies, particularly the IgG4 subclass, are often associated with environmental exposure or the induction of clinical tolerance (Source: PubMed PMID: 19302512). Stemphylium solani is a dematiaceous fungus known to cause gray leaf spot in plants and respiratory symptoms in sensitized humans (Source: American Phytopathological Society). These antibodies serve as important biomarkers for assessing a patient's sensitization profile or their response to allergen-specific immunotherapy, where an increase in 'blocking' IgG is often a desired outcome (Source: Journal of Allergy and Clinical Immunology). They are not considered therapeutic targets in the traditional sense, as they are products of the immune response rather than molecules whose modulation by a drug treats a disease. Consequently, there are no pharmacological agents currently designed to target these specific antibodies, and their clinical relevance remains primarily diagnostic and evaluative.

Other names

Stemphylium solani-specific IgGAnti-Stemphylium solani IgGsIgG to Stemphylium solani

Not applicable